Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

O&G VivasGynaecological health — paediatric, adolescent and congenital

O&G Vivas · Gynaecological health — paediatric, adolescent and congenital

Complete androgen insensitivity — structured oral station (12 minutes)

FRANZCOG oral-format station on complete androgen insensitivity syndrome: the androgen-receptor mechanism with intact AMH and aromatisation, the MRKH differential, the puberty-then-gonadectomy strategy quoting Deans 2012 adult tumour risk, oestrogen replacement with bone protection, and honest disclosure with psychological support. Scored against the eight published RANZCOG oral domains.

clinical4 min readVerification in progress

Target exams

FRANZCOGMRCOGABOGFRCSCMRCPI
On this page
Study tools

Target exams

FRANZCOGMRCOGABOGFRCSCMRCPI
Prompt
You are the gynaecology registrar in the adolescent clinic. A 17-year-old presents with primary amenorrhoea. Her breasts are Tanner stage 5, pubic and axillary hair are scanty, genital examination shows a short blind vagina, and ultrasound finds no uterus. The karyotype returns 46,XY, with testosterone in the male range and an elevated LH. The examiner will ask you to explain the diagnosis and its mechanism at receptors, run the differential against Mullerian agenesis, defend a gonad-management plan including the malignancy numbers, plan hormone replacement, and then manage the disclosure conversation with the patient.

Station format

4 minutes reading, 12 minutes examination, 20 marks, global scoring. The eight published RANZCOG oral domains apply: history and examination; investigations and interpreting results; treatment and management; clinical knowledge; complex, urgent or unusual clinical presentations; rapport; respect; communication skills. You are marked on how you behave, not only what you know. [3]

Reveal the examiner script and model responsesShowHide

Opening prompt — "Explain the diagnosis from receptor to phenotype."

Model response — the mechanism: [1]

  • "This is complete androgen insensitivity syndrome. She is 46,XY with normally differentiated testes making male-range testosterone and anti-Mullerian hormone. The androgen receptor is defective, so androgen cannot act on any target tissue."
  • "Follow the two signals separately: testosterone cannot virilise her, so her external genitalia are female; AMH acts normally, so the Mullerian system regressed in fetal life — hence no uterus and a short blind vagina. At puberty, peripheral aromatisation converts testosterone to oestradiol, giving normal breast development, while androgen-dependent pubic and axillary hair stay scanty. That last point is the giveaway on examination."[1]

Probe 1 — "The registrar next door says this could be Mullerian agenesis. Settle it."

  • "Three questions separate them. First, the androgen-dependent hair: MRKH has normal pubic hair; CAIS is scanty. Second, the karyotype and gonadotrophins: MRKH is 46,XX with normal FSH and LH; CAIS is 46,XY with a raised LH. Third, the gonads: MRKH has functional ovaries and can parent genetically through surrogacy; CAIS has testes that carry a germ-cell tumour risk. This patient's scanty hair, 46,XY, elevated LH and male-range testosterone make CAIS, not MRKH."[1][5]

Probe 2 — "She asked whether 'these lumps in my groin' need to come out. Defend your gonad-management plan."

  • "The plan turns on age. Before and through puberty I retain the testes: the germ-cell tumour risk is very low — of the order of 1 to 2 per cent — and retaining them lets spontaneous oestrogen-driven puberty happen with lifelong bone and cardiovascular benefit. After puberty the risk profile changes: Deans and colleagues pooled the literature in 2012 and estimated the adult risk at about 14 per cent, with reports ranging to 22 per cent."
  • "So I offer laparoscopic bilateral gonadectomy shortly after puberty completes, with counselling that surveillance — imaging and tumour markers — cannot reliably exclude an early tumour if she chooses to keep her gonads. Deans' series also showed that adult women increasingly defer or decline, citing surgical risk and a reluctance to take lifelong hormone replacement; I respect an informed choice either way and document it. If the gonads come out I start oestrogen replacement and protect bone with calcium, vitamin D and bone-density surveillance."[1][2]

Probe 3 — "What do you tell her about sex and children?"

Communication domain — demonstrate empathy out loud while answering: [3][4]

  • "Sexual function: her short vagina does not preclude satisfying sexual function, and if she wants more length, graduated vaginal dilation — taught by an experienced team, at her pace — succeeds in the large majority. I would not offer surgery as a default."
  • "Fertility: she cannot carry a pregnancy and has no oocytes, so her parenting routes are adoption or a partner's or donor gametes with surrogacy where she has a genetic link through family — and I say this plainly, because dishonesty here echoes for life."
  • "Identity: CAIS women identify and live as women. The condition is about receptor biology, not about who she is."[4]

Probe 4 — "Walk me through the disclosure conversation. What do you say, and what must you not say?"

This is a scored communication station — slow down, sit at her level, use her name: [3][4]

  • "I tell her the truth, staged and in plain words: your body makes hormones at puberty normally but responds to them in a particular way; you were born with a variation in how your sex chromosomes and tissues talk to each other; many women have this and most live full female lives; you will not have periods and you will not carry a pregnancy, and we can talk about every route to children when you want to."
  • "I use the word 'difference' or 'variation' rather than 'disorder', I never use older terms, and I do not disclose a karyotype as a verdict about her sex. I offer written information, a named psychologist, and a peer-support group, and I tell her the full answer now — the days of managing CAIS by concealing the 46,XY result are over."[4]

Probe 5 — "Her mother asks: 'Did I cause this, and can it happen again?'"

  • "I reassure on causation: nothing she did or took in pregnancy causes a new androgen-receptor mutation. On recurrence: because the receptor gene sits on the X chromosome, her mother and sisters warrant carrier testing; a carrier has a fifty per cent chance of passing the variant to each 46,XY child. Genetic counselling is part of the management, not an afterthought."[1][4]
Obstetrics & Gynaecology Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]Tadokoro-Cuccaro R, Hughes IA Androgen insensitivity syndrome. Curr Opin Endocrinol Diabetes Obes, 2014.PMID 25354046
  2. [2]Deans R, Creighton SM, Liao LM, Conway GS Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): patient preferences and clinical evidence. Clin Endocrinol (Oxf), 2012.PMID 22211628
  3. [3]Lee PA, Houk CP, Ahmed SF, Hughes IA; International Consensus Conference on Intersex Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics, 2006.PMID 16882788
  4. [4]Lee PA, Nordenström A, Houk CP, et al. Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care. Horm Res Paediatr, 2016.PMID 26820577
  5. [5]Committee on Adolescent Health Care, American College of Obstetricians and Gynecologists ACOG Committee Opinion No. 728: Mullerian Agenesis: Diagnosis, Management, And Treatment. Obstet Gynecol, 2018.PMID 29266078
Obstetrics & Gynaecology Pro

$29/ monthor $279 / year

The complete Obstetrics & Gynaecology library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousColposcopy and treatment of CIN/CGIN — structured oral station (12 minutes)Gynaecological oncology — premalignant cervical diseaseNextTurner syndrome and DSD — structured oral station (12 minutes)Gynaecological health — paediatric, adolescent and congenital